Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 414032
                    [Title] => Good news for 'high blood' patients
                    [Summary] => 
Tired of your expensive drugs for high blood pressure? Tired of spending your hard-earned money for maintenance medicines? Don’t worry for I’ve found affordable and excellent drugs to control your blood pressure.
                    [DatePublished] => 2008-11-11 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 73312
                    [Title] => Mabisang gamot mula sa Unilab-Therapharma
                    [Summary] => 
            
                    [DatePublished] => 2008-07-17 00:00:00
                    [ColumnID] => 134020
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 380529
                    [Title] => Therapharma launches new drug versus diabetes
                    [Summary] => 

Beefing up its cardiometabolic therapeutic armamentarium, Therapharma, a division of Unilab, celebrated the first anniversary of Norizec (glimepiride) with the launch of the country’s first and only combination of glipizide and metformin, recently.


With the theme, "Stronger together: A salute to power and partnership," the launch of the oral combination medicine, will help Filipinos achieve better glycemic control and help prevent complications of diabetes.


                    [DatePublished] => 2007-01-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 373781
                    [Title] => Government, private sector unite for more affordable medicines
                    [Summary] => 

In support of government programs to lower the cost of drugs and President Arroyo’s 10-point agenda for economic recovery, Therapharma Inc., a division of United Laboratories (Unilab), recently launched an affordable and effective brand of amlodipine.  


The new amlodipine is being sold at P17.50, or 60 percent more affordable than the prevailing price of the originator brand, which sells at P44.75. 


This move by Therapharma is an answer to the government’s call to make effective medicines more affordable for more Filipinos.  


                    [DatePublished] => 2006-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 360233
                    [Title] => Treatment cost a major barrier in hypertension management
                    [Summary] => One of the major constraints for controlling hypertension is the limitation of resources for health care, reports the World Health Organization.  


This is particularly true in low- and middle-income countries such as the Philippines, which contribute to 80 percent of the global cardiovascular burden.


                    [DatePublished] => 2006-09-28 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 358054
                    [Title] => Vidastat: Four years and growing stronger
                    [Summary] => Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia.


Vidastat, which became available in 2002, was one of the first drugs to be launched under the pharmacoeconomics campaign which aims to provide safe, effective and affordable drugs for the treatment of chronic diseases.


                    [DatePublished] => 2006-09-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 351899
                    [Title] => Therapharma marks launch of BP drugs
                    [Summary] => 

Therapharma, a division of United Laboratories, recently celebrated the anniversary of the launch of its brand of losartan and the losartan and hydrocholorthiazide combination of antihypertensive medicines.


Hypertension is a major risk factor for heart attack and stroke, two of the leading causes of death in the Philippines.


As with other chronic conditions, hypertension requires daily medication to keep the blood pressure within normal range.


                    [DatePublished] => 2006-08-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 321958
                    [Title] => Economical drug available for diabetics
                    [Summary] => Diabetic patients will now have an easier access to a drug that would help decrease their blood sugar and reduce the risk of complications brought about by the condition. 


Therapharma’s brand of glimepiride which was introduced late last year, is now part of the antidiabetic regimen of many Filipino patients with type 2 diabetes. 


                    [DatePublished] => 2006-02-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 319658
                    [Title] => Glimepiride shown to be effective, safe for diabetes control
                    [Summary] => Glimepiride has been shown to be an effective and safe medicine in lowering blood sugar, providing a precise blood sugar control without the side-effects often associated with other drugs of the same class known as sulfonylureas.


                    [DatePublished] => 2006-02-02 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 315218
                    [Title] => Therapharma gives help to World Vision
                    [Summary] => Therapharma, a division of United Laboratories, recently celebrated the third anniversary of the launch of its brand of simvastatin by joining hands with World Vision, an international Christian organization that sends poor children to school.


John Dumpit, general manager of Therapharma, handed over a check worth P150,000 to broadcast journalist Karen Davila, a World Vision supporter and spokeswoman, representing the company’s donation to the organization’s child sponsorship program. 


                    [DatePublished] => 2006-01-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

THERAPHARMA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 414032
                    [Title] => Good news for 'high blood' patients
                    [Summary] => 
Tired of your expensive drugs for high blood pressure? Tired of spending your hard-earned money for maintenance medicines? Don’t worry for I’ve found affordable and excellent drugs to control your blood pressure.
                    [DatePublished] => 2008-11-11 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 73312
                    [Title] => Mabisang gamot mula sa Unilab-Therapharma
                    [Summary] => 
            
                    [DatePublished] => 2008-07-17 00:00:00
                    [ColumnID] => 134020
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 380529
                    [Title] => Therapharma launches new drug versus diabetes
                    [Summary] => 

Beefing up its cardiometabolic therapeutic armamentarium, Therapharma, a division of Unilab, celebrated the first anniversary of Norizec (glimepiride) with the launch of the country’s first and only combination of glipizide and metformin, recently.


With the theme, "Stronger together: A salute to power and partnership," the launch of the oral combination medicine, will help Filipinos achieve better glycemic control and help prevent complications of diabetes.


                    [DatePublished] => 2007-01-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 373781
                    [Title] => Government, private sector unite for more affordable medicines
                    [Summary] => 

In support of government programs to lower the cost of drugs and President Arroyo’s 10-point agenda for economic recovery, Therapharma Inc., a division of United Laboratories (Unilab), recently launched an affordable and effective brand of amlodipine.  


The new amlodipine is being sold at P17.50, or 60 percent more affordable than the prevailing price of the originator brand, which sells at P44.75. 


This move by Therapharma is an answer to the government’s call to make effective medicines more affordable for more Filipinos.  


                    [DatePublished] => 2006-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 360233
                    [Title] => Treatment cost a major barrier in hypertension management
                    [Summary] => One of the major constraints for controlling hypertension is the limitation of resources for health care, reports the World Health Organization.  


This is particularly true in low- and middle-income countries such as the Philippines, which contribute to 80 percent of the global cardiovascular burden.


                    [DatePublished] => 2006-09-28 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 358054
                    [Title] => Vidastat: Four years and growing stronger
                    [Summary] => Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia.


Vidastat, which became available in 2002, was one of the first drugs to be launched under the pharmacoeconomics campaign which aims to provide safe, effective and affordable drugs for the treatment of chronic diseases.


                    [DatePublished] => 2006-09-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 351899
                    [Title] => Therapharma marks launch of BP drugs
                    [Summary] => 

Therapharma, a division of United Laboratories, recently celebrated the anniversary of the launch of its brand of losartan and the losartan and hydrocholorthiazide combination of antihypertensive medicines.


Hypertension is a major risk factor for heart attack and stroke, two of the leading causes of death in the Philippines.


As with other chronic conditions, hypertension requires daily medication to keep the blood pressure within normal range.


                    [DatePublished] => 2006-08-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 321958
                    [Title] => Economical drug available for diabetics
                    [Summary] => Diabetic patients will now have an easier access to a drug that would help decrease their blood sugar and reduce the risk of complications brought about by the condition. 


Therapharma’s brand of glimepiride which was introduced late last year, is now part of the antidiabetic regimen of many Filipino patients with type 2 diabetes. 


                    [DatePublished] => 2006-02-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 319658
                    [Title] => Glimepiride shown to be effective, safe for diabetes control
                    [Summary] => Glimepiride has been shown to be an effective and safe medicine in lowering blood sugar, providing a precise blood sugar control without the side-effects often associated with other drugs of the same class known as sulfonylureas.


                    [DatePublished] => 2006-02-02 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 315218
                    [Title] => Therapharma gives help to World Vision
                    [Summary] => Therapharma, a division of United Laboratories, recently celebrated the third anniversary of the launch of its brand of simvastatin by joining hands with World Vision, an international Christian organization that sends poor children to school.


John Dumpit, general manager of Therapharma, handed over a check worth P150,000 to broadcast journalist Karen Davila, a World Vision supporter and spokeswoman, representing the company’s donation to the organization’s child sponsorship program. 


                    [DatePublished] => 2006-01-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest